Filing Details
- Accession Number:
- 0001543407-15-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-22 17:01:48
- Reporting Period:
- 2015-05-22
- Filing Date:
- 2015-05-22
- Accepted Time:
- 2015-05-22 17:01:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621793 | Jr E Thomas Polen | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-05-22 | 2,648 | $142.58 | 4,939 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-05-22 | 2,670 | $76.64 | 7,609 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-22 | 1,436 | $142.51 | 6,173 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2015-05-22 | 1,234 | $142.51 | 4,939 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2015-05-22 | 2,670 | $0.00 | 2,670 | $76.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,001 | 2011-11-23 | 2020-11-23 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $142.56 through $142.58. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $142.51 through $142.55. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- The stock appreciation rights vest in four annual installments beginning November 23, 2011.
Billionaire Hedge Funds
